- Home
- OLMA vs BTX Comparison
OLMA vs BTX Comparison
Compare OLMA & BTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OLMA | BTX |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 725.5M | 773.8M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | OLMA | BTX |
|---|---|---|
| Price | $28.96 | $6.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $30.00 | N/A |
| AVG Volume (30 Days) | ★ 8.0M | 919.8K |
| Earning Date | 11-10-2025 | 11-01-2025 |
| Dividend Yield | N/A | ★ 13.80% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.86 | $5.10 |
| 52 Week High | $29.51 | $8.31 |
Technical Indicators
Market Signals| Indicator | OLMA | BTX |
|---|---|---|
| Relative Strength Index (RSI) | 77.91 | 52.08 |
| Support Level | $25.62 | $6.66 |
| Resistance Level | $28.82 | $6.83 |
| Average True Range (ATR) | 2.38 | 0.14 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 87.76 | 82.30 |
Price Performance
Historical ComparisonAbout OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About BTX BlackRock Technology and Private Equity Term Trust Common Shares of Beneficial Interest
BlackRock Technology and Private Equity Term Trust objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust will invest in equity securities issued by mid - and small capitalization companies that the Trust's adviser believes have above-average earnings growth potential.